JPH08133940A - Ultraviolet absorbing agent and cosmetic containing the same - Google Patents

Ultraviolet absorbing agent and cosmetic containing the same

Info

Publication number
JPH08133940A
JPH08133940A JP26949194A JP26949194A JPH08133940A JP H08133940 A JPH08133940 A JP H08133940A JP 26949194 A JP26949194 A JP 26949194A JP 26949194 A JP26949194 A JP 26949194A JP H08133940 A JPH08133940 A JP H08133940A
Authority
JP
Japan
Prior art keywords
ultraviolet
cherry
absorbing agent
cosmetic
ultraviolet absorbing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP26949194A
Other languages
Japanese (ja)
Inventor
Akio Fujii
昭男 藤井
Kenkichi Matsubara
顕吉 松原
Retsu Hara
烈 原
Yasuji Osato
保治 大郷
Satoshi Ohata
智 大畑
Yoshiyuki Miyata
善之 宮田
Yoshio Kitada
好男 北田
Takuji Nakajima
琢自 中島
Yoshihiro Mimaki
祥浩 三巻
Yutaka Sashita
豊 指田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Priority to JP26949194A priority Critical patent/JPH08133940A/en
Publication of JPH08133940A publication Critical patent/JPH08133940A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: To obtain an ultraviolet absorbing agent containing neosakuranin existing in the bark of cherry tree as an active component, exhibiting excellent ultraviolet absorbing action in both ultraviolet A and B regions and having high safety and to prepare a cosmetic containing the absorbing agent. CONSTITUTION: This ultraviolet absorbing agent composed of neosakuranin is produced e.g. by adding 1-20 pts. of a polar solvent to 1 pt. of the bark of cherry tree and extracting at room temperature or by heating at a temperature near the boiling point of the solvent. A cosmetic having excellent effect to protect the skin from ultraviolet rays can be produced by compounding the ultraviolet absorbing agent. The amount of the ultraviolet absorbing agent to be compounded to the cosmetic is preferably 0.1-5wt.%. Neosakuranin has absorptions in both ultraviolet A and B regions. The percent absorption of the absorption peak (at 370nm) in the ultraviolet A region is as high as 700 and the agent is suitable as an ultraviolet absorbing agent. The cherry is e.g. Yoshino cherry, Japanese hill cherry or Oshima cherry (Prunus larmesiana). Above all, Oshima cherry is preferable because of its high neosakuranin content. The cosmetic is continuously usable over a long period.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は紫外線吸収剤及びこれを
含有する化粧料に関し、詳しくは、ネオサクラニンから
なる紫外線吸収剤及びこれを含有する紫外線からの皮膚
防護効果に優れる化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an ultraviolet absorber and a cosmetic containing the same, and more particularly to an ultraviolet absorber containing neosacranin and a cosmetic containing the same, which is excellent in skin protection effect from ultraviolet rays.

【0002】[0002]

【従来の技術】近年、炎症や皮膚癌誘発の危険性がある
ことから、紫外線Bを中心に、紫外線からの皮膚防護に
ついての消費者の意識が高まっている。更に、紫外線A
についても安全性上好ましくないことが多数の学会で指
摘され、これに対する防護の必要性が強調されている。
2. Description of the Related Art In recent years, due to the risk of inflammation and induction of skin cancer, consumers have been conscious of protecting the skin from UV rays, especially UV rays B. Furthermore, ultraviolet rays A
It was pointed out by many academic societies that this is not preferable in terms of safety, and the need for protection against this was emphasized.

【0003】この様な状況のなか、化粧料の分野におい
ては今までに、紫外線に対する防護の方法として、酸化
チタン等の隠蔽剤を化粧料に配合することによって紫外
線を散乱させてしまう方法や、ベンゾフェノン誘導体、
桂皮酸誘導体、パラアミノ安息香酸誘導体等の紫外線吸
収剤を化粧料に配合して、紫外線が皮膚に至る以前にそ
れらに吸収させてしまう方法等が取られていた。
Under these circumstances, in the field of cosmetics, as a method of protecting against ultraviolet rays, a method of scattering ultraviolet rays by compounding a cosmetic with a masking agent such as titanium oxide, Benzophenone derivative,
A method has been used in which an ultraviolet absorber such as a cinnamic acid derivative or a paraaminobenzoic acid derivative is mixed with cosmetics so that the ultraviolet rays are absorbed by the cosmetics before they reach the skin.

【0004】しかしながら、酸化チタンによる散乱によ
る保護では、防護に有効な量の酸化チタンを配合する
と、酸化チタンの外観色の影響を受け異常に白くなった
り、例え他の有色顔料を配合して調色したとしても、厚
ぼったい感じの仕上がりになってしまい不自然な感じを
他人に与えかねなかった。また、従来の紫外線吸収剤は
遅延型アレルギーの原因物質と疑われる等、安全性上の
問題も少なくなかった。更に、これまでの紫外線吸収剤
は何れも、紫外線Bは吸収できても紫外線Aを吸収する
作用がないため紫外線Aに対する防護が全くできず、紫
外線防護作用が十分であるとは言えなかった。
However, in the case of protection due to scattering by titanium oxide, if a titanium oxide in an amount effective for protection is added, the appearance color of the titanium oxide is affected and the color becomes abnormally white. Even if it was colored, the finish would be thick and could give an unnatural feeling to others. In addition, conventional UV absorbers have many safety problems such as suspected causative substances of delayed-type allergy. Further, any of the ultraviolet absorbers up to now can absorb ultraviolet B but have no effect of absorbing ultraviolet A, and therefore cannot protect against ultraviolet A at all, and it cannot be said that the ultraviolet protective effect is sufficient.

【0005】一方、ネオサクラニンは既知物質であり、
サクラの樹皮中に存在することが知られている化合物で
あるが、この化合物が紫外線吸収作用を有することは知
られておらず、また、これを化粧料に配合して、皮膚を
紫外線から防護しようとした報告も全く知られていな
い。
On the other hand, neosacranin is a known substance,
It is a compound that is known to exist in the bark of cherry blossoms, but it is not known that this compound has a UV-absorbing effect, and it has been incorporated into cosmetics to protect the skin from UV rays. There are no known reports of attempts.

【0006】[0006]

【発明が解決しようとする課題】本発明は、上記観点か
らなされたものであり、紫外線A、紫外線Bの両方を吸
収する作用に優れ、更に、安全性に優れた紫外線吸収
剤、及びこれを含有する紫外線からの肌の防護作用に優
れた化粧料を提供することを課題とする。
SUMMARY OF THE INVENTION The present invention has been made from the above viewpoints, and an ultraviolet absorber excellent in the action of absorbing both ultraviolet rays A and ultraviolet rays B, and further excellent in safety, and An object of the present invention is to provide a cosmetic having an excellent action of protecting the skin from the contained ultraviolet rays.

【0007】[0007]

【課題を解決するための手段】本発明者らは、上記課題
を解決するために各種有機化合物について紫外線吸収ス
ペクトルを指標に、紫外線A及びB領域に強度の吸収を
有する物質を捜し求めたところ、一般式(I)に示され
るネオサクラニンが紫外線A及びBの両領域に優れた吸
収作用を有し、更に、安全性にも優れることを見出し、
また、これを配合した化粧料が紫外線からの肌の防護作
用に優れることを見出し、本発明を完成するに至った。
In order to solve the above-mentioned problems, the inventors of the present invention searched various organic compounds for substances having strong absorption in the ultraviolet A and B regions using the ultraviolet absorption spectrum as an index. It has been found that neosacranin represented by the general formula (I) has an excellent absorbing action in both the ultraviolet rays A and B regions, and is also excellent in safety,
Further, they have found that a cosmetic containing the same has an excellent action of protecting the skin from ultraviolet rays, and completed the present invention.

【0008】すなわち本発明は、下記一般式(I)に示
されるネオサクラニンからなる紫外線吸収剤及びこれを
含有する化粧料である。
That is, the present invention is an ultraviolet absorber consisting of neosacranin represented by the following general formula (I) and a cosmetic containing the same.

【0009】[0009]

【化2】 Embedded image

【0010】<1>本発明の紫外線吸収剤 本発明の紫外線吸収剤は、前記一般式(I)で表される
ネオサクラニンからなる。
<1> Ultraviolet Absorber of the Present Invention The ultraviolet absorber of the present invention comprises neosacranin represented by the general formula (I).

【0011】上記ネオサクラニンは、バラ科の植物であ
るサクラの樹皮中に高濃度で存在し、サクラの全種に渡
って広く存在していることが知られている。そこで、ネ
オサクラニンの起源植物として用いるサクラとしては、
サクラであれば特に種類を問わずどんなサクラも挙げら
れるが、例えば、ソメイヨシノ、ヤマザクラ、オオシマ
ザクラ等が好ましく挙げられ、これらのうちでも、ネオ
サクラニンの含有量が最も多いオオシマザクラをより好
ましく挙げることができる。
It is known that the above-mentioned neo-Sacranin is present at a high concentration in the bark of the cherry tree which is a plant of the Rosaceae family, and is widely present in all species of the cherry tree. So, as the cherry tree used as the source plant of Neo-Sacranin,
Any type of cherry can be used as long as it is not particularly limited. For example, Yoshino cherry, Yamazakura, Oshimazakura, etc. are preferable, and among these, Oshimazakura with the highest content of neo-Sakuranin is more preferable.

【0012】ネオサクラニンをサクラの樹皮より得る方
法であるが、例えば、サクラの樹皮に1〜20倍量の極
性溶媒を加え、室温或いは溶媒の沸点付近の温度で加熱
して抽出すればよい。この時、原料のサクラの樹皮はそ
のまま用いてもよいし、乾燥、細切、粉砕などの前処理
をして用いても構わない。抽出時間は、室温であれば数
日、加熱下であれば数時間が適当である。この様にして
得られる抽出物から溶媒を除去した後、液液抽出、カラ
ムクロマトグラフィー等の通常の方法で精製することに
より、本発明の紫外線吸収剤であるネオサクラニンが得
られる。
[0012] A method for obtaining neo-Sacranin from the bark of Sakura is, for example, 1 to 20 times the amount of a polar solvent is added to the bark of Sakura, and extraction may be performed by heating at room temperature or a temperature near the boiling point of the solvent. At this time, the bark of the raw material, cherry bark, may be used as it is, or may be used after being subjected to pretreatment such as drying, shredding, and crushing. The extraction time is suitable for several days at room temperature and for several hours under heating. After removing the solvent from the extract thus obtained, it is purified by a usual method such as liquid-liquid extraction and column chromatography to obtain neo-Sacranin which is the ultraviolet absorbent of the present invention.

【0013】また、上記抽出に用いる極性溶媒として
は、メタノールやエタノール等のアルコール類、アセト
ンやメチルエチルケトン等のケトン類、ジエチルエーテ
ルやテトラヒドロフラン等のエーテル類、クロロホルム
や塩化メチレン等のハロゲン化炭化水素類、酢酸エチル
や蟻酸メチル等のエステル類、アセトニトリル等のニト
リル類、水等を好適に例示できる。また、これら極性溶
媒は、一種を単独で用いてもよいし、数種を混合して用
いてもよい。
The polar solvent used for the above extraction includes alcohols such as methanol and ethanol, ketones such as acetone and methyl ethyl ketone, ethers such as diethyl ether and tetrahydrofuran, halogenated hydrocarbons such as chloroform and methylene chloride. Preferred examples thereof include esters such as ethyl acetate and methyl formate, nitriles such as acetonitrile, water and the like. Moreover, these polar solvents may be used individually by 1 type, and may mix and use several types.

【0014】この様にして得られるネオサクラニンは、
紫外部A及びBの両領域に吸収を持っており、取り分け
紫外線A領域における吸収極大(370nm)の%吸光
度係数は700と高く、本発明の紫外線吸収剤として好
適である。
Neo-Sacranin thus obtained is
It has absorption in both ultraviolet A and B regions, and in particular, it has a high% absorbance coefficient of 700 at the absorption maximum (370 nm) in the ultraviolet A region, which is suitable as the ultraviolet absorber of the present invention.

【0015】<2>本発明の化粧料 本発明の化粧料は、上記紫外線吸収剤を配合したもので
ある。本発明の化粧料における上記紫外線吸収剤の好ま
しい配合量は、0.01〜10重量%であり、0.1〜
5重量%であることがより好ましい。紫外線吸収剤の配
合量が0.01重量%未満では、紫外線吸収能が十分で
あるとは言えず紫外線からの肌の防護効果が不十分にな
ることがあり、10重量%を越えて配合しても効果が頭
打ちになり経済的でないことがある。また、紫外線から
の肌の防護効果が顕著であり、経済的にも有利な紫外線
吸収剤配合量の範囲は、上述したより好ましい配合量の
範囲すなわち0.1〜5重量%である。
<2> Cosmetic of the present invention The cosmetic of the present invention contains the above ultraviolet absorber. The preferable blending amount of the ultraviolet absorber in the cosmetic of the present invention is 0.01 to 10% by weight,
It is more preferably 5% by weight. If the blending amount of the UV absorber is less than 0.01% by weight, it cannot be said that the UV absorbing ability is sufficient and the effect of protecting the skin from UV rays may be insufficient. However, the effect may reach the ceiling and may not be economical. Further, the range of the amount of the ultraviolet absorber compounded, which has a remarkable effect of protecting the skin from ultraviolet rays and is economically advantageous, is the above-mentioned more preferable range of the compounded amount, that is, 0.1 to 5% by weight.

【0016】本発明の化粧料には、上記紫外線吸収剤の
他に、通常化粧料に用いられる各種任意成分、例えば、
ワセリン、スクワラン、流動パラフィン等の炭化水素
類、ホホバ油、カルナバワックス、合成ゲイロウ、ミツ
ロウなどのエステル類、オリーブ油、水添ヤシ油、ヒマ
シ油、牛脂等のトリグリセライド類、セチルアルコー
ル、オレイルアルコール、ベヘニルアルコール、バチル
アルコール等の高級アルコール類、ステアリン酸やオレ
イン酸等の高級脂肪酸類、ステアリン酸モノグリセライ
ドやポリオキシエチレン硬化ヒマシ油等のノニオン界面
活性剤類、ラウリル硫酸ナトリウムやスルホコハク酸エ
ステル等のアニオン界面活性剤類、アルキルアミン塩酸
塩等のカチオン界面活性剤類、アルキルベタイン等の両
性界面活性剤類、グリセリンや1,3−ブタンジオール
等の多価アルコール類、エタノール、プロパノール等の
低級アルコール類、パラベン類やグルコン酸クロルヘキ
シジン等の防腐剤類、ビタミンEやブチルヒドロキシト
ルエン等の酸化防止剤、グァーガム、アラビアゴム、カ
ルボキシビニルポリマー等の増粘剤、ポリエチレングリ
コール等の保湿剤、アルカリやリン酸塩、クエン酸塩、
酢酸塩等のpH調整剤、酸化チタン、ベンガラ、黄色酸
化鉄、タルク、シリカゲル等の粉体類、香料、色素等、
ヒアルロン酸、胎盤抽出物、朝鮮人参エキス、ステロー
ル配糖体等の各種目的に応じた薬効成分などが適宜選択
されて配合される。
In the cosmetic of the present invention, in addition to the above-mentioned ultraviolet absorber, various optional components usually used in cosmetics, for example,
Hydrocarbons such as petrolatum, squalane, liquid paraffin, esters such as jojoba oil, carnauba wax, synthetic gay wax, beeswax, olive oil, hydrogenated coconut oil, castor oil, triglycerides such as beef tallow, cetyl alcohol, oleyl alcohol, behenyl alcohol , Higher alcohols such as batyl alcohol, higher fatty acids such as stearic acid and oleic acid, nonionic surfactants such as stearic acid monoglyceride and polyoxyethylene hydrogenated castor oil, anionic surface active agents such as sodium lauryl sulfate and sulfosuccinate Agents, cationic surfactants such as alkylamine hydrochloride, amphoteric surfactants such as alkylbetaine, polyhydric alcohols such as glycerin and 1,3-butanediol, lower alcohols such as ethanol and propanol, Preservatives such as benzene and chlorhexidine gluconate, antioxidants such as vitamin E and butylhydroxytoluene, thickeners such as guar gum, gum arabic, carboxyvinyl polymer, moisturizers such as polyethylene glycol, alkalis and phosphates. , Citrate,
PH adjusting agents such as acetate, titanium oxide, red iron oxide, yellow iron oxide, talc, powders such as silica gel, fragrances, pigments, etc.
Hyaluronic acid, placenta extract, ginseng extract, sterol glycoside, and other medicinal components suitable for various purposes are appropriately selected and mixed.

【0017】また、本発明の化粧料には、紫外線吸収剤
であるネオサクラニン以外の紫外線吸収剤あるいは紫外
線防御剤を配合してもよく、この様な成分としては、例
えば、ベンゾフェノン誘導体、アミノ安息香酸誘導体、
桂皮酸誘導等の紫外線吸収剤や酸化チタンや酸化亜鉛の
様な紫外線を散乱させる作用を有する無機粉体等が挙げ
られる。
Further, the cosmetic of the present invention may contain an ultraviolet absorber or an ultraviolet protector other than the ultraviolet absorber neosacranin. Examples of such components include benzophenone derivatives and aminobenzoic acid. Derivative,
Examples thereof include a cinnamic acid-derived ultraviolet absorber and an inorganic powder such as titanium oxide and zinc oxide having an action of scattering ultraviolet rays.

【0018】本発明の化粧料の剤型は、特に限定はされ
ないが、例えば、クリーム、乳液、化粧水などの様に皮
膚に塗布する基礎化粧料が好ましい。また、アイカラ
ー、チークカラー、ファンデーション、アンダーメーク
アップ等のメークアップ化粧料に配合してもよい。これ
らは、本発明の紫外線吸収剤であるネオサクラニンを配
合する以外は、通常の化粧料と同様の方法で製造するこ
とができる。
The dosage form of the cosmetic of the present invention is not particularly limited, but basic cosmetics such as cream, milky lotion, lotion and the like which are applied to the skin are preferable. Moreover, you may mix | blend with makeup cosmetics, such as eye color, cheek color, foundation, and undermakeup. These can be produced in the same manner as in ordinary cosmetics, except that neosacranin, which is the ultraviolet absorber of the present invention, is added.

【0019】[0019]

【実施例】以下に、本発明の実施例を説明する。まず、
本発明の紫外線吸収剤の実施例について説明する。
EXAMPLES Examples of the present invention will be described below. First,
Examples of the ultraviolet absorbent of the present invention will be described.

【0020】[0020]

【実施例1】 ネオサクラニンの製造 オオシマザクラの樹皮800gにメタノール5Lを加
え、3時間の加熱還流を行った。得られた抽出液を濾過
して不溶物を除去した後、減圧濃縮により濾液より抽出
溶媒を除去した。得られた濃縮物にクロロホルムと水を
1Lづつ加え液液抽出を行った後、これからクロロホル
ム層だけを取り出した。この溶液からクロロホルムを除
去し、残留物に、更に、ノルマルブタノールと水をそれ
ぞれ1Lづつ加え、液液抽出を行い、これからノルマル
ブタノール層だけを取り出した。この溶液からノルマル
ブタノールを除去し、得られた粗製物をシリカゲルカラ
ムクロマトグラフィーにより精製(溶出溶媒;クロロホ
ルム:メタノール=100:0→50:50)して47
1mgのネオサクラニン(紫外線吸収剤1)を得た。
Example 1 Production of Neo-Sacranin To 5 g of methanol was added to 800 g of bark of Japanese cherry tree, and the mixture was heated under reflux for 3 hours. The obtained extract was filtered to remove insoluble matter, and then the extract solvent was removed from the filtrate by concentration under reduced pressure. Chloroform and water (1 L) were added to the obtained concentrate to perform liquid-liquid extraction, and then only the chloroform layer was taken out. Chloroform was removed from this solution, and 1 L each of normal butanol and water were further added to the residue, liquid-liquid extraction was performed, and only the normal butanol layer was taken out from this. Normal butanol was removed from this solution, and the resulting crude product was purified by silica gel column chromatography (elution solvent; chloroform: methanol = 100: 0 → 50: 50) to give 47.
1 mg of neosacranin (ultraviolet absorber 1) was obtained.

【0021】<本発明の紫外線吸収剤の評価>上記で得
られたネオサクラニン(紫外線吸収剤1)の安全性に関
して、以下の3種類の試験を行った。
<Evaluation of Ultraviolet Absorber of the Present Invention> The following three types of tests were conducted on the safety of neosacranin (ultraviolet absorber 1) obtained above.

【0022】(1)モルモットによる経皮毒性試験 ハートレー系雄性モルモット(300−350g)6匹
の背部を剃毛し、2×2cmの部位を3箇所作った。そ
のうちの1箇所については、無処置コントロール部位と
し、剃毛以後は何も操作をしなかった。残りの2箇所の
うち1箇所にはベヒクルコントロールとして、ワセリン
0.05gを塗布した。残る1箇所は検体投与部位とし
て、紫外線吸収剤1を10重量%の割合でワセリン中に
混練りしたもの0.05gを塗布した。その後、24時
間後及び48時間後に、同じ箇所に同じ検体を同様に投
与し、最終投与の72時間後に皮膚反応を下記のドレー
ズの基準を用いて判定した。
(1) Dermal Toxicity Test by Guinea Pigs The backs of six Hartley male guinea pigs (300-350 g) were shaved to make 2 × 2 cm sites at 3 sites. One of them was set as an untreated control site, and no operation was performed after shaving. As a vehicle control, 0.05 g of vaseline was applied to one of the remaining two places. The remaining one site was a sample administration site, and 0.05 g of the ultraviolet absorber 1 kneaded in vaseline at a ratio of 10% by weight was applied. Then, 24 hours and 48 hours later, the same specimen was similarly administered to the same site, and 72 hours after the final administration, the skin reaction was evaluated using the following Draize standard.

【0023】(ドレーズの基準) − : 無反応 ± : 疑陽性反応 + : 陽性反応 ++ : 浮腫を伴う反応(Criteria for Draize) −: No reaction ±: False positive reaction +: Positive reaction ++: Reaction with edema

【0024】結果は、何れの部位も皮膚反応を認めず
(−)の判定であった。これより、本発明の紫外線吸収
剤は安全性に優れることがわかる。
The result was judged as (-), because no skin reaction was observed at any part. From this, it is understood that the ultraviolet absorber of the present invention is excellent in safety.

【0025】(2)モルモットによるアレルギー性試験
(マキシマイゼーションテスト) 10匹づつ2群の雄性白色種ハートレー系モルモットの
背部を剃毛し、1%ラウリル硫酸ナトリウム水溶液を塗
布して剃毛部を損傷させた後、そのうちの1群の損傷部
には、紫外線吸収剤1を1重量%の割合でワセリン中に
混練りしたものを、もう一方の群の損傷部には、ベヒク
ルコントロール群としてワセリンのみを、それぞれ48
時間クローズドパッチした。
(2) Allergenicity test with guinea pigs (maximization test) The backs of two groups of 10 male white Hartley guinea pigs were shaved on 10 groups and the shaving site was damaged by applying a 1% sodium lauryl sulfate aqueous solution. After that, one part of the damaged part was kneaded with UV absorber 1 in vaseline at a ratio of 1% by weight, and the other part of the damaged part was only vaseline as a vehicle control group. 48 for each
Time closed patch.

【0026】クローズパッチ処理の終了から24時間後
及び72時間後に、各群のモルモットのクローズドパッ
チした部位に、紫外線吸収剤含有ワセリン投与群には、
1重量%の紫外線吸収剤1を含有する10%DMSO生
理食塩水溶液、フロイントの完全アジュバント(FC
A)、2重量%の紫外線吸収剤1を含有する10%DM
SO生理食塩水溶液とFCAの1:1の混合乳化物を、
ベヒクルコントロール群には、10%DMSO生理食塩
水溶液、FCA、10%DMSO生理食塩水溶液とFC
Aの1:1の混合物を、それぞれ2箇所づつ、計6箇所
の皮内注射を行った。注射後10日間の休止期間をお
き、その後、24時間のクローズドパッチを行い惹起反
応を見た。紫外線吸収剤1の惹起濃度は1重量%と0.
1重量%ととし、ベヒクルにはワセリンを用いた。クロ
ーズドパッチ除去後1時間及び24時間後に皮膚反応を
上記のドレーズの基準を用いて観察した。
24 hours and 72 hours after the end of the closed patch treatment, guinea pigs of each group were subjected to the closed patch site, and to the ultraviolet absorber-containing petrolatum-administered group,
10% DMSO saline solution containing 1% by weight of UV absorber 1, Freund's complete adjuvant (FC
A) 10% DM containing 2% by weight of UV absorber 1
1: 1 mixed emulsion of SO saline solution and FCA,
Vehicle control group, 10% DMSO saline solution, FCA, 10% DMSO saline solution and FC
The 1: 1 mixture of A was injected intradermally at 2 sites each, for a total of 6 sites. After a 10-day rest period after injection, a 24-hour closed patch was performed to observe the evoked response. The concentration of the ultraviolet absorber 1 was 1% by weight and 0.
1% by weight, and vaseline was used as the vehicle. Skin reactions were observed 1 and 24 hours after removal of the closed patch using the Draize criteria above.

【0027】結果は何れの検体投与部位も無反応(−)
を示し、本発明の紫外線吸収剤がアレルギー性を有して
いないことが明らかになった。
As a result, no reaction (-) was observed at any of the test substance administration sites.
It was revealed that the ultraviolet absorber of the present invention has no allergenicity.

【0028】(3)人におけるクローズドパッチテスト 健康な男子11名の上腕内側部を試験部位として、ここ
に、リント布上に0.025gの5重量%濃度で紫外線
吸収剤1を含有するワセリンを塗布したものを24時間
クローズドパッチした。クローズドパッチ終了後、試験
部位から検体を除去し、その1時間後及び24時間後
に、下記に示す本邦パッチテスト基準を指標に皮膚反応
を観察した。
(3) Closed-patch test in humans The upper arm inner part of 11 healthy males was used as a test site, and 0.025 g of petrolatum containing ultraviolet absorber 1 at a concentration of 5% by weight was added onto lint cloth. The applied product was closed-patched for 24 hours. After completion of the closed patch, the specimen was removed from the test site, and 1 hour and 24 hours thereafter, the skin reaction was observed using the Japanese patch test criteria shown below as an index.

【0029】(本邦パッチテスト基準) − : 無反応 ± : 疑陽性反応 + : 陽性反応 ++ : 浮腫を伴う反応(Japanese patch test standard) −: No reaction ±: False positive reaction +: Positive reaction ++: Reaction with edema

【0030】結果は、何れの観察時における何れのパネ
ラーの反応も無反応(−)であった。これより本発明の
紫外線吸収剤は安全性に優れることがわかる。次に、上
記実施例1で得られた紫外線吸収剤1を含有する化粧料
の実施例について説明する。尚、以下に示す配合量は全
て重量部である。
As a result, the reaction of any panelist at any observation was no reaction (-). From this, it is understood that the ultraviolet absorber of the present invention is excellent in safety. Next, examples of cosmetics containing the ultraviolet absorbent 1 obtained in Example 1 will be described. In addition, the compounding amounts shown below are all parts by weight.

【0031】[0031]

【実施例2、3】 化粧水 表1に示す処方成分を80℃で加熱撹拌し可溶化した
後、冷却し化粧水を得た。
Examples 2 and 3 Lotion A lotion was obtained by heating and stirring the prescription components shown in Table 1 at 80 ° C. to solubilize and then cooling.

【0032】[0032]

【表1】 [Table 1]

【0033】[0033]

【実施例4、5】 クリーム 表2に示すA成分、B成分をそれぞれ秤込み、別々に8
0℃で加熱撹拌した後、A成分にB成分を撹拌しながら
徐々に加え、乳化した。これを撹拌しながら冷却してク
リームを得た。
Examples 4 and 5 Cream A component and B component shown in Table 2 were weighed and separately 8
After heating and stirring at 0 ° C., the component B was gradually added to the component A with stirring to emulsify. This was cooled with stirring to obtain a cream.

【0034】[0034]

【表2】 [Table 2]

【0035】[0035]

【実施例6】 ファンデーション 表3のA成分を混練りした後、B成分を加え更に混練り
した。これを80℃に加熱した後、C成分を加えて分散
させ、更に80℃で加熱溶解したD成分を徐々に加え乳
化し、撹拌冷却してファンデーションを得た。
Example 6 Foundation After kneading component A in Table 3, component B was added and further kneading. After heating this at 80 ° C., the component C was added and dispersed, and the component D heated and dissolved at 80 ° C. was gradually added to emulsify and stirred to cool to obtain a foundation.

【0036】[0036]

【表3】 [Table 3]

【0037】<本発明の化粧料の評価>上記実施例5で
得られたクリームを用いて、本発明の化粧料の紫外線防
護作用を評価した。
<Evaluation of Cosmetics of the Present Invention> Using the cream obtained in Example 5 above, the ultraviolet protection effect of the cosmetics of the present invention was evaluated.

【0038】男子パネラー5名を被験者とし、まず、被
験者の下腕内側部にSEランプとBLBランプの1:1
の混色光を照射して、この混色光における最少紅斑濃度
(MED)を求めた。次に、被験者の下腕内側部に、実
施例5のクリーム0.025gを塗布し、その部分にM
EDの2倍の光量の上記混色光を照射し、照射終了から
10時間後及び24時間後に皮膚の炎症反応を上記本邦
パッチテスト基準に基づいて観察した。
Five male panelists were used as subjects. First, SE lamps and BLB lamps were placed on the inside of the lower arm of the subjects at a ratio of 1: 1.
Then, the minimum erythema density (MED) in this mixed color light was determined. Next, 0.025 g of the cream of Example 5 was applied to the inner part of the lower arm of the subject, and M was applied to the part.
Irradiation with the above-mentioned mixed-color light in an amount twice that of ED was performed, and 10 hours and 24 hours after the end of irradiation, the skin inflammatory reaction was observed based on the Japanese patch test standard.

【0039】結果は何れも無反応であり、紫外線Bに対
する保護が十分されていたことが明らかになった。ま
た、光の照射から10日後及び30日後に照射部位の黒
化を観察したが、何れの部位も黒化を認められず、紫外
線Aに対する保護も十分にされていたことがわかる。
The results showed that there was no reaction, and that the protection against ultraviolet B was sufficient. Further, blackening of the irradiated site was observed 10 days and 30 days after the light irradiation, but no blackening was observed in any of the sites, indicating that the protection against ultraviolet rays A was sufficient.

【0040】[0040]

【発明の効果】本発明の紫外線吸収剤は、紫外線A、紫
外線Bの両方を吸収する作用に優れ、更に、安全性にも
優れる。また、これを含有する化粧料は、紫外線吸収特
性を有するので紫外線から肌を防護することができ、更
に、安全性にも優れるため長期連続使用が可能である。
EFFECT OF THE INVENTION The ultraviolet absorbent of the present invention is excellent in the function of absorbing both ultraviolet rays A and B, and is also excellent in safety. In addition, the cosmetics containing the same can protect the skin from ultraviolet rays because they have an ultraviolet absorbing property, and since they are excellent in safety, they can be used continuously for a long period of time.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C09K 3/00 104 B // C07D 309/10 (72)発明者 大郷 保治 神奈川県横浜市神奈川区高島台27番地1ポ ーラ化成工業株式会社横浜研究所内 (72)発明者 大畑 智 神奈川県横浜市神奈川区高島台27番地1ポ ーラ化成工業株式会社横浜研究所内 (72)発明者 宮田 善之 神奈川県横浜市神奈川区高島台27番地1ポ ーラ化成工業株式会社横浜研究所内 (72)発明者 北田 好男 神奈川県横浜市戸塚区柏尾町560ポーラ化 成工業株式会社戸塚研究所内 (72)発明者 中島 琢自 神奈川県横浜市戸塚区柏尾町560ポーラ化 成工業株式会社戸塚研究所内 (72)発明者 三巻 祥浩 東京都八王子市めじろ台2−8−5−205 (72)発明者 指田 豊 東京都八王子市南陽台3−20−7─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display location C09K 3/00 104 B // C07D 309/10 (72) Inventor Hoji Osato Kanagawa-ku, Yokohama, Kanagawa Takashimadai 27 1-Polar Chemical Industry Co., Ltd. Yokohama Research Laboratory (72) Inventor Satoshi Ohata 27 Takatakadai 27-Polar Chemical Industry Co., Ltd. Yokohama Research Laboratory (72) Inventor Yoshiyuki Miyata 1 Polla Kasei Kogyo Co., Ltd. 1-27 Takashimadai, Kanagawa-ku, Yokohama-shi, Kanagawa (72) Inventor Yoshio Kitada 560 Kashio-cho, Totsuka-ku, Yokohama, Kanagawa Pref. Inventor Takuji Nakajima 560, Kashio-cho, Totsuka-ku, Yokohama-shi, Kanagawa Pola Chemical Industry Co., Ltd. Totsuka Research Institute (72) Inventor Yoshihiro Maki Tokyo Prince City Mejirodai 2-8-5-205 (72) inventor Yutaka Sashida Hachioji, Tokyo Nan'yodai 3-20-7

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 下記一般式(I)に示されるネオサクラ
ニンからなる紫外線吸収剤。 【化1】
1. An ultraviolet absorber comprising neo-sacranin represented by the following general formula (I). Embedded image
【請求項2】 請求項1記載の紫外線吸収剤を含有する
化粧料。
2. A cosmetic containing the ultraviolet absorbent according to claim 1.
【請求項3】 前記紫外線吸収剤の含有量が、化粧料全
量に対して0.01〜10重量%である請求項2記載の
化粧料。
3. The cosmetic according to claim 2, wherein the content of the ultraviolet absorber is 0.01 to 10% by weight based on the total amount of the cosmetic.
JP26949194A 1994-11-02 1994-11-02 Ultraviolet absorbing agent and cosmetic containing the same Pending JPH08133940A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26949194A JPH08133940A (en) 1994-11-02 1994-11-02 Ultraviolet absorbing agent and cosmetic containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26949194A JPH08133940A (en) 1994-11-02 1994-11-02 Ultraviolet absorbing agent and cosmetic containing the same

Publications (1)

Publication Number Publication Date
JPH08133940A true JPH08133940A (en) 1996-05-28

Family

ID=17473183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26949194A Pending JPH08133940A (en) 1994-11-02 1994-11-02 Ultraviolet absorbing agent and cosmetic containing the same

Country Status (1)

Country Link
JP (1) JPH08133940A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1104672A1 (en) * 1999-12-02 2001-06-06 Laboratoires Serobiologiques(Societe Anonyme) Cosmetic and/or pharmaceutical compositions
US20100203175A1 (en) * 2007-07-09 2010-08-12 Basf Beauty Care Solutions France S.A.S. DEGLYCATION OF AGEs

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1104672A1 (en) * 1999-12-02 2001-06-06 Laboratoires Serobiologiques(Societe Anonyme) Cosmetic and/or pharmaceutical compositions
WO2001039738A3 (en) * 1999-12-02 2002-04-18 Cognis France Sa Use of flavones and/or isoflavones from plant extracts
US20100203175A1 (en) * 2007-07-09 2010-08-12 Basf Beauty Care Solutions France S.A.S. DEGLYCATION OF AGEs

Similar Documents

Publication Publication Date Title
JPH11263720A (en) Antiaging agent
DE69839040T2 (en) FOUNTAIN CRACK EXTRACT CONTAINING PREPARATION FOR EXTERNAL APPLICATION
KR101854840B1 (en) Mask pack comprising pozzolan
JPS61260008A (en) Cosmetic composition
JP3582936B2 (en) External preparation for skin
KR101598623B1 (en) UV blocking agents containing ethylhexyltriazone and the preparation method thereof, and the cosmetic composition containing the same
JPH08301722A (en) Skin cosmetic
JP2986966B2 (en) Melanin production inhibitor
JPH11349435A (en) Skin agent used for external use and effective for preventing and improving pigmentary symptom caused by ultraviolet light
JPH08133940A (en) Ultraviolet absorbing agent and cosmetic containing the same
JP3412931B2 (en) 2,4,6-trihydroxychalcone and cosmetics containing it
JPH08133955A (en) Skin preparation for external use
JPH08133939A (en) Ultraviolet absorbing agent and cosmetic containing the same
JPH08133941A (en) Ultraviolet absorbing agent and cosmetic containing the same
CN115024994A (en) High-safety sunscreen composition and preparation method and application thereof
JPH10194982A (en) Collagenase inhibitor and skin lotion for senescence prevention containing the same
JPH10158143A (en) Photo-aging prevention and improving agent and skin cosmetic
JP3597520B2 (en) External preparation for skin
JP3207996B2 (en) Sunscreen cosmetics
JP2004123661A (en) Skin care preparation for external use
JPH09175988A (en) Agent for preventing light-induced aging of skin and preparation for external use for skin
JPS61254510A (en) External agent for skin
JPS62181213A (en) Long-wavelength ultraviolet light absorber
JP3150845B2 (en) UV absorbers and UV protection cosmetics containing the same
EP0620000A2 (en) Cosmetic or pharmaceutical use of N-acylalcanolamines